BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22138691)

  • 1. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
    Guo G; Gui Y; Gao S; Tang A; Hu X; Huang Y; Jia W; Li Z; He M; Sun L; Song P; Sun X; Zhao X; Yang S; Liang C; Wan S; Zhou F; Chen C; Zhu J; Li X; Jian M; Zhou L; Ye R; Huang P; Chen J; Jiang T; Liu X; Wang Y; Zou J; Jiang Z; Wu R; Wu S; Fan F; Zhang Z; Liu L; Yang R; Liu X; Wu H; Yin W; Zhao X; Liu Y; Peng H; Jiang B; Feng Q; Li C; Xie J; Lu J; Kristiansen K; Li Y; Zhang X; Li S; Wang J; Yang H; Cai Z; Wang J
    Nat Genet; 2011 Dec; 44(1):17-9. PubMed ID: 22138691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.
    Sourbier C; Srivastava G; Ghosh MC; Ghosh S; Yang Y; Gupta G; Degraff W; Krishna MC; Mitchell JB; Rouault TA; Linehan WM
    Oncotarget; 2012 Nov; 3(11):1472-82. PubMed ID: 23178531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
    Morris MR; Hughes DJ; Tian YM; Ricketts CJ; Lau KW; Gentle D; Shuib S; Serrano-Fernandez P; Lubinski J; Wiesener MS; Pugh CW; Latif F; Ratcliffe PJ; Maher ER
    Anticancer Res; 2009 Nov; 29(11):4337-43. PubMed ID: 20032376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HIF1α in renal cell carcinoma tumorigenesis.
    Gudas LJ; Fu L; Minton DR; Mongan NP; Nanus DM
    J Mol Med (Berl); 2014 Aug; 92(8):825-36. PubMed ID: 24916472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.
    Szendrői A; Szász AM; Kardos M; Tőkés AM; Idan R; Szűcs M; Kulka J; Nyirády P; Szendrői M; Szállási Z; Győrffy B; Tímár J
    Oncotarget; 2016 Jul; 7(27):42086-42098. PubMed ID: 27244898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of PI3K signalling pathway in clear cell renal cell carcinoma in relation to VHL and HIF status.
    Tumkur Sitaram R; Landström M; Roos G; Ljungberg B
    J Clin Pathol; 2021 Apr; 74(4):216-222. PubMed ID: 32467322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
    Niu X; Zhang T; Liao L; Zhou L; Lindner DJ; Zhou M; Rini B; Yan Q; Yang H
    Oncogene; 2012 Feb; 31(6):776-86. PubMed ID: 21725364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP37 promotes deubiquitination of HIF2α in kidney cancer.
    Hong K; Hu L; Liu X; Simon JM; Ptacek TS; Zheng X; Liao C; Baldwin AS; Zhang Q
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13023-13032. PubMed ID: 32461361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model.
    Gstalder C; Ader I; Cuvillier O
    Mol Cancer Ther; 2016 Oct; 15(10):2465-2474. PubMed ID: 27507852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
    Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO
    Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.
    Casagrande S; Ruf M; Rechsteiner M; Morra L; Brun-Schmid S; von Teichman A; Krek W; Schraml P; Moch H
    J Pathol; 2013 Mar; 229(4):525-34. PubMed ID: 23007793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VHL promotes immune response against renal cell carcinoma via NF-κB-dependent regulation of VCAM-1.
    Labrousse-Arias D; Martínez-Alonso E; Corral-Escariz M; Bienes-Martínez R; Berridy J; Serrano-Oviedo L; Conde E; García-Bermejo ML; Giménez-Bachs JM; Salinas-Sánchez AS; Sánchez-Prieto R; Yao M; Lasa M; Calzada MJ
    J Cell Biol; 2017 Mar; 216(3):835-847. PubMed ID: 28235946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-30c-2-3p and miR-30a-3p: new pieces of the jigsaw puzzle in HIF2α regulation.
    Moch H; Lukamowicz-Rajska M
    Cancer Discov; 2014 Jan; 4(1):22-4. PubMed ID: 24402943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular biology of renal cell carcinoma.
    Keefe SM; Nathanson KL; Rathmell WK
    Semin Oncol; 2013 Aug; 40(4):421-8. PubMed ID: 23972705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element.
    Xu J; Wang B; Xu Y; Sun L; Tian W; Shukla D; Barod R; Grillari J; Grillari-Voglauer R; Maxwell PH; Esteban MA
    Oncogene; 2012 Feb; 31(8):1065-72. PubMed ID: 21841824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.
    Luu VD; Boysen G; Struckmann K; Casagrande S; von Teichman A; Wild PJ; Sulser T; Schraml P; Moch H
    Clin Cancer Res; 2009 May; 15(10):3297-304. PubMed ID: 19401348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The uremic toxin p-cresyl sulfate induces proliferation and migration of clear cell renal cell carcinoma via microRNA-21/ HIF-1α axis signals.
    Wu TK; Wei CW; Pan YR; Hsu RJ; Wu CY; Yu YL
    Sci Rep; 2019 Mar; 9(1):3207. PubMed ID: 30824757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid in Renal Carcinoma: Queen Bee to Target?
    Tan SK; Welford SM
    Trends Cancer; 2020 Jun; 6(6):448-450. PubMed ID: 32459999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.